Prof. Dr. Arndt Vogel
Arndt Vogel is a Principal Investigator in SP7 and a member of the Curriculum Committee.
His research focus lies on translational and clinical research concerning hepatobiliary malignancies.
Prof. Vogel is currently a ESMO faculty member for Gastrointestinal Tumors, non-colorectal, and served as coordinator of the ESMO Clinical Practice Guideline Biliary Tract Cancer in 2021. From 2020 to 2024, he was a ESMO Membership Committee Member. He has served as a research group leader since 2004 and head of the AIO group “Hepatobiliary cancers” since 2010.
| Year | Position |
|---|---|
| Since 2021 | Head of the center for Personalized Medicine, MHH |
| Since 2018 | Coordinator of the ESMO Clinical Practice Guideline HCC |
| Since 2016 | Head of the Visceral-Oncological Center, MHH |
| Since 2009 | Senior Consultant in Internal Medicine, MHH |
| 2010 | Board Certification “Gastroenterology” |
| 2009 | Venia legendi, Internal Medicine, MHH |
| 2008 | Board Certification “Internal Medicine” |
| 2004-2009 | Internal Medicine Fellowship, MHH |
| 2002-2004 | Postdoctoral Fellow, OHSU, Portland, Oregon, US |
| 2000-2002 | Internal Medicine Fellowship, MHH |
| 1999 | Dr. med. (“magna cum laude”), Dr. Binder/Prof. Oellerich, Dept. of Clinical Chemistry Universität Göttingen |
| 1998-1999 | Internal Medicine Internship, Zentral Krankenhaus Mitte, Bremen |
| 1991-1997 | Studies of Human Medicine, University of Göttingen |